| CK | Creatine kinase |
| AKI | Acute kidney injury |
| DDI | Drug-drug interaction |
| FDA | Food and Drug Administration |
| FAERS | FDA Adverse Event Reporting System |
| ADE | Adverse drug event |
| HMG-CoA | Hydroxymethylglutaryl-CoA |
| ROR | Reporting odds ratio |
| CI | Confidence interval |
| ARM | Association rule mining |
| CYP3A4 | Cytochrome p450 3A4 |
| GSD | Glycogen storage disease |
| OMIM | Online Mendelian Inheritance in Man |
| KEGG | Kyoto Encyclopedia of Genes and Genomes |
| OATP1B1 | Organic anion transporting polypeptide 1B1 |
| OAT3 | Organic anion transporter 3 |
| DYSF | Dysferlin |
| DES | Desmin |
| PLEC | Plectin |
| CAPN3 | Calpain 3 |
| SCN4A | Sodium Channel, Voltage-Gated, Type IV α Subunit |
| TNNT1 | Troponin T1, Slow Skeletal Type |
| SDHA | Succinate Dehydrogenase Complex Flavoprotein Subunit A |
| MYH7 | Myosin Heavy Chain 7 |
| PYGM | Muscle Glycogen Phosphorylase |
| LPIN1 | Lipin 1 |
| PGAM2 | Phosphoglycerate mutase |